China Pharma Holdings, Inc. CPHI
Set alert
0.60 USD -0.02 -3.81%
As of Nov 2, 10:15 AM ET
0.60 Day range 0.6199
0.38 52-week range 19.19
- YTD
- -50.32%
- 1 year
- -63.35%
- Open
- 0.6195
- Prev close
- 0.6249
- Mkt cap
- 25.81M
- Vol
- 14.51K
- Avg vol
- 1.89M
- EPS
- -0.42
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.60
- High
- 0.6199
- Forward P/E
- 0.00
- Beta
- 0.71
- Short ratio
- 0.22
- Inst. own
- 0.21%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.214
- 200-d avg
- 0.2588
- 1y target
- 0.00
1m chart
Built from the cached one-day intraday bars.
Signals (14)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 2:17 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:17 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:17 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:44 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:40 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:39 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:08 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:47 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:40 PM | 2 days ago |
| SMA: Bearish | Oct 30, 11:53 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:30 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:28 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:22 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:58 AM | 3 days ago |
Financial health
Altman Z-Score
-0.06 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 5
Valuation
P/E -1.6×
FY 2016 5y median -20.9× FY 2025
P/S 1.3×
FY 2016 5y median 9.1× FY 2025
P/B 0.2×
FY 2016 5y median 8.6× FY 2025
P/FCF 472×
FY 2016 5y median -90.2× FY 2025
EV/EBITDA -5.8×
FY 2016 5y median -5.8× FY 2025
EV/Sales 2.1×
FY 2016 5y median 9.6× FY 2025
FCF Yield 0.2%
FY 2016 5y median -0.3% FY 2025
Profitability
Gross Margin -3.2%
FY 2016 5y median -4.0% FY 2025
Operating Margin -74.5%
FY 2016 5y median -43.8% FY 2025
Net Margin -76.9%
FY 2016 5y median -49.0% FY 2025
ROE -14.0%
FY 2016 5y median -56.5% FY 2025
ROIC -11.3%
FY 2016 5y median -21.4% FY 2025
ROA -10.3%
FY 2016 5y median -18.7% FY 2025
Growth (YoY)
Revenue -8.5%
FY 2016 FY 2025
Operating Income 32.7%
FY 2016 FY 2025
EPS (diluted) -174.1%
FY 2016 FY 2025
Free Cash Flow 101.5%
FY 2016 FY 2025
Financial Health
Current Ratio 0.3×
FY 2016 5y median 0.7× FY 2025
Quick Ratio 0.1×
FY 2016 5y median 0.2× FY 2025
Debt / Equity 0.2×
FY 2016 5y median 0.6× FY 2025
Net Debt / EBITDA -2.4×
FY 2016 5y median -1.5× FY 2025
Interest Coverage -30.3×
FY 2016 5y median -8.2× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31